Inventor
TIMOTHY RICHARD COON
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds23%
C07BGeneral methods of organic chemistry9%
A61JContainers specially adapted for medical or pharmaceutical purposes6%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
12,319,693Crystalline forms of CFTR modulators202512,168,009Modulators of cystic fibrosis transmembrane conductance regulator202412,122,788Process of making CFTR modulators202411,873,300Crystalline forms of CFTR modulators202411,866,450Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators202411,713,324Gonadotropin-releasing hormone receptor antagonists and methods relating thereto202311,591,350Modulators of cystic fibrosis transmembrane conductance regulator202311,584,761Process of making CFTR modulators202311,426,407Modulators of cystic fibrosis transmembrane conductance regulator2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to VERTEX PHARMA (8)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to NEUROCRINE BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 8 | 2022–2025 |
| NEUROCRINE BIOSCIENCES INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2025 |